In this issue of Dermatologic Clinics, guest editor Dr. Jeffrey M. Cohen brings his considerable expertise to the topic of Psoriasis: Contemporary and Future Therapies. Top experts in the field discuss oral therapies for psoriasis; phototherapy for psoriasis in the era of biologics; the psoriasis treatment pipeline; psoriasis comorbidities and their impact on treatment; underdiagnosis and undertreatment of traditional cardiovascular risk factors in psoriasis; and much more.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Erratum - p. xiii 8. Preface - p. xv 9. Biologics for Psoriasis - p. 339 10. Oral Psoriasis Therapies - p. 357 11. The Psoriasis Treatment Pipeline: An Overview and Update - p. 365 12. Evolving Landscape of Biologic Therapy for Pediatric Psoriasis - p. 377 13. Treatment of Nail Psoriasis - p. 387 14. Phototherapy for Psoriasis in the Age of Biologics - p. 399 15. Psoriasis Comorbidities and Their Treatment Impact - p. 405 16. Using Guidelines of Care to Lower Cardiovascular Risk in Patients with Psoriasis - p. 417 17. Prevention of Psoriatic Arthritis: The Need for Prospective Studies - p. 429 18. The Role of Genetics on Psoriasis Susceptibility, Comorbidities, and Treatment Response - p. 439 19. Paradoxical Psoriasis - p. 471 20. Immune Checkpoint Inhibitor-Induced Psoriasis: Diagnosis, Management, and a Review of Cases - p. 481 21. Adherence to Psoriasis Therapies - p. 495 22. Disparities in Care for Psoriasis - p. 507
In this issue of Dermatologic Clinics, guest editor Dr. Jeffrey M. Cohen brings his considerable expertise to the topic of Psoriasis: Contemporary and Future Therapies. Top experts in the field discuss oral therapies for psoriasis; phototherapy for psoriasis in the era of biologics; the psoriasis treatment pipeline; psoriasis comorbidities and their impact on treatment; underdiagnosis and undertreatment of traditional cardiovascular risk factors in psoriasis; and much more.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Erratum - p. xiii 8. Preface - p. xv 9. Biologics for Psoriasis - p. 339 10. Oral Psoriasis Therapies - p. 357 11. The Psoriasis Treatment Pipeline: An Overview and Update - p. 365 12. Evolving Landscape of Biologic Therapy for Pediatric Psoriasis - p. 377 13. Treatment of Nail Psoriasis - p. 387 14. Phototherapy for Psoriasis in the Age of Biologics - p. 399 15. Psoriasis Comorbidities and Their Treatment Impact - p. 405 16. Using Guidelines of Care to Lower Cardiovascular Risk in Patients with Psoriasis - p. 417 17. Prevention of Psoriatic Arthritis: The Need for Prospective Studies - p. 429 18. The Role of Genetics on Psoriasis Susceptibility, Comorbidities, and Treatment Response - p. 439 19. Paradoxical Psoriasis - p. 471 20. Immune Checkpoint Inhibitor-Induced Psoriasis: Diagnosis, Management, and a Review of Cases - p. 481 21. Adherence to Psoriasis Therapies - p. 495 22. Disparities in Care for Psoriasis - p. 507
